GL1X · GenesisL1 explorer

MolNFT v1 · #161311 · protein

Crystal structure of human arginase-1 at pH 9.0 in complex with cb- 1158/INCB001158

6QAF: “Crystal structure of human arginase-1 at pH 9.0 in complex with cb- 1158/INCB001158”. X-ray diffraction, 3 ligands (XC3, MN, NA), 6 pockets (best druggability 0.73). MolNFT v1 #161311 on GenesisL1: 3D structure, binding sites and…

PDB
6QAF
Type
protein
Length
636 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arginase-1
EC
3.5.3.1
UniProt
P05089
Ligands
XC3, MN, NA
Pockets
6 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BArginase-1 (EC 3.5.3.1)protein31844% helix, 16% strandP05089

Ligands and binding sites

  • XC3 · [(~{E})-3-[(3~{S},4~{R})-4-azanyl-1-[(2~{S})-2-azanylpropanoyl]-4-carboxy-pyrrolidin-3-yl]prop-1-enyl]-tris(oxidanyl)boranium · ligand · 2 copies · chains A, B
  • MN · Manganese (II) ion · metal · 4 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.730.8440empty
26380.670.7671XC3
3930.430.7921XC3
4550.370.8014empty
5520.360.7913empty

Interfaces

1 interface between chains.

  • A–B · 480 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6QAF · Crystal structure of human Arginase-1 at pH 9.0 in complex with CB-1158/INCB001158 · the same entry in another collection · chain A against A, TM-score 1.00
  • P05089 · AlphaFold monomer V2.0 prediction for arginase-1 (P05089) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.